138 related articles for article (PubMed ID: 17222397)
21. Lysophosphatidic acid is a potential mediator of cholestatic pruritus.
Kremer AE; Martens JJ; Kulik W; Ruëff F; Kuiper EM; van Buuren HR; van Erpecum KJ; Kondrackiene J; Prieto J; Rust C; Geenes VL; Williamson C; Moolenaar WH; Beuers U; Oude Elferink RP
Gastroenterology; 2010 Sep; 139(3):1008-18, 1018.e1. PubMed ID: 20546739
[TBL] [Abstract][Full Text] [Related]
22. The effects of EPA, DHA, and aspirin ingestion on plasma lysophospholipids and autotaxin.
Block RC; Duff R; Lawrence P; Kakinami L; Brenna JT; Shearer GC; Meednu N; Mousa S; Friedman A; Harris WS; Larson M; Georas S
Prostaglandins Leukot Essent Fatty Acids; 2010; 82(2-3):87-95. PubMed ID: 20106646
[TBL] [Abstract][Full Text] [Related]
23. [Significance of serum autotaxin activity in gastrointestinal disease].
Ikeda H; Watanabe N; Nakamura K; Kume Y; Nakai Y; Fujishiro M; Omata M; Igarashi K; Yokota H; Yatomi Y
Rinsho Byori; 2009 May; 57(5):445-9. PubMed ID: 19522250
[TBL] [Abstract][Full Text] [Related]
24. Autotaxin (lysoPLD/NPP2) protects fibroblasts from apoptosis through its enzymatic product, lysophosphatidic acid, utilizing albumin-bound substrate.
Song J; Clair T; Noh JH; Eun JW; Ryu SY; Lee SN; Ahn YM; Kim SY; Lee SH; Park WS; Yoo NJ; Lee JY; Nam SW
Biochem Biophys Res Commun; 2005 Nov; 337(3):967-75. PubMed ID: 16219296
[TBL] [Abstract][Full Text] [Related]
25. Autotaxin as a novel serum marker of liver fibrosis.
Nakagawa H; Ikeda H; Nakamura K; Ohkawa R; Masuzaki R; Tateishi R; Yoshida H; Watanabe N; Tejima K; Kume Y; Iwai T; Suzuki A; Tomiya T; Inoue Y; Nishikawa T; Ohtomo N; Tanoue Y; Omata M; Igarashi K; Aoki J; Koike K; Yatomi Y
Clin Chim Acta; 2011 Jun; 412(13-14):1201-6. PubMed ID: 21419756
[TBL] [Abstract][Full Text] [Related]
26. Role of lysophosphatidic acid in the regulation of uterine leiomyoma cell proliferation by phospholipase D and autotaxin.
Billon-Denis E; Tanfin Z; Robin P
J Lipid Res; 2008 Feb; 49(2):295-307. PubMed ID: 18024704
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of lysophospholipase D activity by unsaturated lysophosphatidic acids or seed extracts containing 1-linoleoyl and 1-oleoyl lysophosphatidic acid.
Liu XW; Sok DE; Yook HS; Sohn CB; Chung YJ; Kim MR
J Agric Food Chem; 2007 Oct; 55(21):8717-22. PubMed ID: 17887800
[TBL] [Abstract][Full Text] [Related]
28. Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase.
Tokumura A; Majima E; Kariya Y; Tominaga K; Kogure K; Yasuda K; Fukuzawa K
J Biol Chem; 2002 Oct; 277(42):39436-42. PubMed ID: 12176993
[TBL] [Abstract][Full Text] [Related]
29. The molecular mechanism of cholestatic pruritus.
Oude Elferink RP; Kremer AE; Martens JJ; Beuers UH
Dig Dis; 2011; 29(1):66-71. PubMed ID: 21691108
[TBL] [Abstract][Full Text] [Related]
30. Lysophospholipase D and its role in LPA production.
Xie Y; Meier KE
Cell Signal; 2004 Sep; 16(9):975-81. PubMed ID: 15212758
[TBL] [Abstract][Full Text] [Related]
31. Deficiency of autotaxin/lysophospholipase D results in head cavity formation in mouse embryos through the LPA receptor-Rho-ROCK pathway.
Koike S; Keino-Masu K; Masu M
Biochem Biophys Res Commun; 2010 Sep; 400(1):66-71. PubMed ID: 20692235
[TBL] [Abstract][Full Text] [Related]
32. Site-directed mutations in the tumor-associated cytokine, autotaxin, eliminate nucleotide phosphodiesterase, lysophospholipase D, and motogenic activities.
Koh E; Clair T; Woodhouse EC; Schiffmann E; Liotta L; Stracke M
Cancer Res; 2003 May; 63(9):2042-5. PubMed ID: 12727817
[TBL] [Abstract][Full Text] [Related]
33. Lysophosphatidic acids, cyclic phosphatidic acids and autotaxin as promising targets in therapies of cancer and other diseases.
Gendaszewska-Darmach E
Acta Biochim Pol; 2008; 55(2):227-40. PubMed ID: 18560605
[TBL] [Abstract][Full Text] [Related]
34. Scalable purification and characterization of the extracellular domain of human autotaxin from prokaryotic cells.
Haga A; Hashimoto K; Tanaka N; Nakamura KT; Deyashiki Y
Protein Expr Purif; 2008 May; 59(1):9-17. PubMed ID: 18249559
[TBL] [Abstract][Full Text] [Related]
35. Cyclic phosphatidic acid is produced by autotaxin in blood.
Tsuda S; Okudaira S; Moriya-Ito K; Shimamoto C; Tanaka M; Aoki J; Arai H; Murakami-Murofushi K; Kobayashi T
J Biol Chem; 2006 Sep; 281(36):26081-8. PubMed ID: 16837466
[TBL] [Abstract][Full Text] [Related]
36. Production of bioactive lysophosphatidic acid by lysophospholipase D in hen egg white.
Morishige J; Touchika K; Tanaka T; Satouchi K; Fukuzawa K; Tokumura A
Biochim Biophys Acta; 2007 Apr; 1771(4):491-9. PubMed ID: 17321793
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms of lysophosphatidic acid production.
Aoki J
Semin Cell Dev Biol; 2004 Oct; 15(5):477-89. PubMed ID: 15271293
[TBL] [Abstract][Full Text] [Related]
38. Crystallization and preliminary X-ray crystallographic analysis of human autotaxin.
Inoue K; Tanaka N; Haga A; Yamasaki K; Umeda T; Kusakabe Y; Sakamoto Y; Nonaka T; Deyashiki Y; Nakamura KT
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2011 Apr; 67(Pt 4):450-3. PubMed ID: 21505238
[TBL] [Abstract][Full Text] [Related]
39. Lipopolysaccharide induces autotaxin expression in human monocytic THP-1 cells.
Li S; Zhang J
Biochem Biophys Res Commun; 2009 Jan; 378(2):264-8. PubMed ID: 19027716
[TBL] [Abstract][Full Text] [Related]
40. [The Laboratory Medicine of Lipid Mediators].
Yatomi Y
Rinsho Byori; 2015 Oct; 63(10):1183-6. PubMed ID: 26897854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
